Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
10.90
+0.53 (5.11%)
At close: Oct 9, 2025, 4:00 PM EDT
11.00
+0.10 (0.92%)
After-hours: Oct 9, 2025, 7:58 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.32 billion as of October 9, 2025. Its market cap has increased by 9.18% in one year.
Market Cap
1.32B
Enterprise Value
783.52M
1-Year Change
9.18%
Ranking
Category
Stock Price
$10.90
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.32B, an increase of 668.12%. That is a compound annual growth rate of 34.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 1.26B | 48.54% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | 678.78M | 263.23% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.87B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |